FDA — authorised 29 May 2013
- Application: NDA203085
- Marketing authorisation holder: BAYER HLTHCARE
- Indication: Labeling
- Status: approved
🇺🇸 Stivarga in United States
FDA authorised Stivarga on 29 May 2013
Marketing authorisation
Stivarga in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Stivarga approved in United States?
Yes. FDA authorised it on 29 May 2013.
Who is the marketing authorisation holder for Stivarga in United States?
BAYER HLTHCARE holds the US marketing authorisation.